Article info
PDFExtended report
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study
- Correspondence to:
Dr D E Furst
Division of Rheumatology, Department of Medicine, University of California Los Angeles,32–59 Rehabilitation Center, 1000 Veteran Avenue, Los Angeles, CA 90095–1670, USA;DEFurst{at}mednet.ucla.edu
Citation
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study
Publication history
- Accepted February 26, 2007
- First published April 5, 2007.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Annals of the Rheumatic Diseases